COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,722 Articles (22,913 medRxiv, 8,809 bioRxiv)

Most recent first Previous |  Page 3034: Articles 30331-30340  | Next

Currently available intravenous immunoglobulin (Gamunex(C)-C and Flebogamma(C) DIF) contains antibodies reacting against SARS-CoV-2 antigens
Diez, J.-M., Romero, C., Gajardo, R.
10.1101/2020.04.07.029017 — Posted: 2020-04-10 Discussion: Offsite
Single-cell atlas of a non-human primate reveals new pathogenic mechanisms of COVID-19
Han, L., Wei, X., Liu, C., Volpe, G., Wang, Z., Pan, T., Yuan, Y., Lei, Y., Lai, Y., Ward, C., Yu, Y., Wang, M., Shi, Q., Wu, T., Wu, L., Liu, Y., Wang, C., Zhang, Y., Sun, H., Yu, H., Zhuang, Z., Tang, T., Huang, Y., Lu, H., Xu, L., Xu, J., Cheng, M., Liu, Y., Wong, C. W., Tan, T., Ji, W., Maxwell, P. H., Yang, H., Wang, J., Zhu, S., Liu, S., Xu, X., Hou, Y., Esteban, M. A., Liu, L.
10.1101/2020.04.10.022103 — Posted: 2020-04-10 Discussion: Onsite
Nonmedical Masks in Public for Respiratory Pandemics: Droplet Retention by two-layer Textile Barrier Fully Protects Germ-free Mice from Bacteria in Droplets
Rodriguez-Palacios, A., Conger, M., Cominelli, F.
10.1101/2020.04.06.028688 — Posted: 2020-04-10
Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility
Stawiski, E. W., Diwanji, D., Suryamohan, K., Gupta, R., Fellouse, F. A., Sathirapongsasuti, F., Liu, J., Jiang, Y.-P., Ratan, A., Mis, M., Santhosh, D., Somasekar, S., Mohan, S., Phalke, S., Kuriakose, B., Antony, A., Junutula, J. R., Schuster, S. C., Jura, N., Seshagiri, S.
10.1101/2020.04.07.024752 — Posted: 2020-04-10 Discussion: Onsite | Offsite
Systemic analysis of tissue cells potentially vulnerable to SARS-CoV-2 infection by the protein-proofed single-cell RNA profiling of ACE2, TMPRSS2 and Furin proteases
Zhou, L., Niu, Z., Jiang, X., Zhang, Z., Zheng, Y., Wang, Z., Zhu, Y., Gao, L., Wang, X., Sun, Q.
10.1101/2020.04.06.028522 — Posted: 2020-04-10 Discussion: Offsite
ACE2 fragment as a decoy for novel SARS-Cov-2 virus
Renzi, F., Ghersi, D.
10.1101/2020.04.06.028647 — Posted: 2020-04-10
On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2
Correa Giron, C., Laaksonen, A., Barroso da Silva, F. L.
10.1101/2020.04.05.026377 — Posted: 2020-04-10 Discussion: Onsite
Rapid in silico design of antibodies targeting SARS-CoV-2 using machine learning and supercomputing
Desautels, T., Zemla, A., Lau, E., Franco, M., Faissol, D.
10.1101/2020.04.03.024885 — Posted: 2020-04-10
Optimization of SARS-CoV-2 detection by RT-QPCR without RNA extraction
Merindol, N., Pepin, G., Marchand, C., Rheault, M., Peterson, C., Poirier, A., Germain, H., Danylo, A.
10.1101/2020.04.06.028902 — Posted: 2020-04-10 Discussion: Onsite
BioLaboro: A bioinformatics system for detecting molecular assay signature erosion and designing new assays in response to emerging and reemerging pathogens
Holland, M., Negron, D., Mitchell, S., Dellinger, N., Ivancich, M., Barrus, T., Thomas, S., Jennings, K. W., Goodwin, B. G., Sozhamannan, S.
10.1101/2020.04.08.031963 — Posted: 2020-04-10 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).